| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/25/2001 | WO2001036642A1 HUMAN MONOCLONAL ANTIBODIES AGAINST TGF-βII RECEPTOR AND MEDICINAL USE THEREOF |
| 05/25/2001 | WO2001036610A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | WO2001036605A2 2786, a human aminopeptidase |
| 05/25/2001 | WO2001036604A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 05/25/2001 | WO2001036599A1 Microparticle-based transfection and activation of dendritic cells |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036479A1 G-protein coupled receptor |
| 05/25/2001 | WO2001036454A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 05/25/2001 | WO2001036451A1 Vitamin e derivatives |
| 05/25/2001 | WO2001036440A1 23 human secreted proteins |
| 05/25/2001 | WO2001036425A2 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 05/25/2001 | WO2001036420A1 Tricyclic azaindolizine derivatives having an spla2- inhibiting effect |
| 05/25/2001 | WO2001036403A1 Urea derivatives as anti-inflammatory agents |
| 05/25/2001 | WO2001036398A1 Benzoxa- and benzthiazoles |
| 05/25/2001 | WO2001036376A1 Novel phenylalanine derivatives |
| 05/25/2001 | WO2001036374A2 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 05/25/2001 | WO2001036360A1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 05/25/2001 | WO2001035995A2 Tr3-specific binding agents and methods for their use |
| 05/25/2001 | WO2001035975A2 Treatment of subnormal bone mineral density |
| 05/25/2001 | WO2001035968A1 Methods for inducing chondrogenesis and producing de novo cartilage in vitro |
| 05/25/2001 | WO2001035966A1 Boron compounds and complexes as anti-inflammatory agents |
| 05/25/2001 | WO2001035960A1 Use of substituted 4-(quinolin 2-yl-methoxy)phenyl-acetic acid derivatives for the treatment of diseases |
| 05/25/2001 | WO2001035936A2 Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides for the treatment of diseases |
| 05/25/2001 | WO2000078320A8 Cartilage enhancing food supplements and methods of preparing the same |
| 05/25/2001 | WO2000064469A3 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2392090A1 G-protein coupled receptor |
| 05/25/2001 | CA2392076A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | CA2391530A1 Tr3-specific binding agents and methods for their use |
| 05/25/2001 | CA2391087A1 Imidazole compounds as phosphodiesterase vii inhibitors |
| 05/25/2001 | CA2390431A1 Treatment of subnormal bone mineral density |
| 05/25/2001 | CA2389862A1 Human monoclonal antibody against tgf-.beta.ii receptor and medicinal use thereof |
| 05/25/2001 | CA2388922A1 23 human secreted proteins |
| 05/23/2001 | EP1100963A2 Human ccr-2 gene polymorphisms |
| 05/23/2001 | EP1100913A1 Mekk1 serine threonine kinases -interacting fha forkhead associated domain protein 1 (mif1) |
| 05/23/2001 | EP1100909A2 Dna replication- and repair-associated proteins |
| 05/23/2001 | EP1100908A2 Human receptor-associated proteins |
| 05/23/2001 | EP1100907A2 Human cytoskeletal proteins |
| 05/23/2001 | EP1100896A1 Dna encoding snorf33 receptor |
| 05/23/2001 | EP1100887A1 Growth differentiation factor-11 |
| 05/23/2001 | EP1100882A1 Human protein kinase h2lau20 |
| 05/23/2001 | EP1100880A2 Urate oxidase |
| 05/23/2001 | EP1100871A2 Method for preparing a cartilage cell suspension |
| 05/23/2001 | EP1100869A1 98 human secreted proteins |
| 05/23/2001 | EP1100829A2 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases |
| 05/23/2001 | EP1100827A2 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases |
| 05/23/2001 | EP1100826A1 Isoforms of human calcium sensing receptor |
| 05/23/2001 | EP1100823A2 Novel peptides for use in immunotherapy of autoimmune diseases |
| 05/23/2001 | EP1100822A1 Secreted cysteine rich protein-6 (scrp-6) |
| 05/23/2001 | EP1100814A2 Inhibitors of urokinase and blood vessel formation |
| 05/23/2001 | EP1100813A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | EP1100805A1 Medicine nitrate salts |
| 05/23/2001 | EP1100797A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 05/23/2001 | EP1100792A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 05/23/2001 | EP1100767A1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 05/23/2001 | EP1100542A2 Peg-urate oxidase conjugates and use thereof |
| 05/23/2001 | EP1100535A1 Targeting pharmaceutical agents to injured tissues |
| 05/23/2001 | EP1100525A2 Modulation of apoptosis |
| 05/23/2001 | EP1100506A1 Integrin receptor antagonists |
| 05/23/2001 | EP1100505A1 A PHARMACEUTICAL COMBINATION COMPRISING A COX-2 INHIBITOR AND A iNOS INHIBITOR |
| 05/23/2001 | EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 05/23/2001 | EP1100493A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100492A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100488A1 Use of creatine compounds for treatment of bone or cartilage cells and tissues |
| 05/23/2001 | EP1100485A1 Substituted anilide compounds and methods |
| 05/23/2001 | EP1100471A1 Compressed compositions comprising clarified xanthan gum |
| 05/23/2001 | DE19955476A1 Bis-basische Verbindungen als Tryptase-Inhibitoren, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Bis-basic compounds as tryptase inhibitors, to processes for their preparation and their use as medicaments |
| 05/23/2001 | CN1296529A Method for screening therapeutic agents |
| 05/23/2001 | CN1296488A Bicycle hydroxamic acid derivatives |
| 05/23/2001 | CN1296481A (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 05/23/2001 | CN1296474A Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 05/23/2001 | CN1296011A Purine L-nucleoside, its analogue and use thereof |
| 05/23/2001 | CN1295862A Medicine for treating osteoporosis and hyperosteogeny and preparation process thereof |
| 05/23/2001 | CN1295857A Plaster |
| 05/23/2001 | CN1295849A Shanggu Huoxue adhesive plaster for traumatic injuries |
| 05/23/2001 | CN1295841A Adhesive plaster for osteophytosis |
| 05/23/2001 | CN1066150C Bridged indole as matrix metalloprotease inhibitors |
| 05/23/2001 | CN1066149C Diazepino-indoles as phosphodiesterase IV inhibitors |
| 05/23/2001 | CN1066046C Plaster for treating rheumatism and preparation process thereof |
| 05/23/2001 | CN1066043C Traditional Chinese medicinal for treating hyperosteogeny and prolapse of lumbar intervertebral disc |
| 05/22/2001 | US6235969 Cloning pigs using donor nuclei from non-quiescent differentiated cells |
| 05/22/2001 | US6235877 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 05/22/2001 | US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis |
| 05/22/2001 | US6235768 Osteoporosis; rheumatic disorders; antitumor agents |
| 05/22/2001 | US6235760 Treatment for CNS injuries |
| 05/22/2001 | US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide |
| 05/22/2001 | US6235750 Nitric oxide synthase inhibitor |
| 05/22/2001 | US6235747 6-phenyl-pyridin-2-ylamine derivatives |
| 05/22/2001 | US6235732 Neurokinin antagonists |
| 05/22/2001 | US6235727 Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and use |
| 05/22/2001 | US6235723 Antisense oligonucleotide modulation of human protein kinase C-δ expression |
| 05/22/2001 | US6235714 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 05/22/2001 | US6235287 Extract of curcuma amada plant and a compound selected from ocimene, dihydro-ocimene, piene/a-/, curcumene-alpha and beta, linalool, cuminyl alcohol, keto-alchol, turmerone, linalyl acetate, ssfrole, carene-3, myrcene, cineol, limonene |
| 05/17/2001 | WO2001034827A1 Antisense modulation of rank expression |
| 05/17/2001 | WO2001034805A2 Human vanilloid receptor gene |
| 05/17/2001 | WO2001034801A2 Recombinant gelatin in vaccines |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034785A1 Novel metalloprotease having aggrecanase activity |
| 05/17/2001 | WO2001034768A2 15 human secreted proteins |